Cargando…

Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020

The polymerase chain reaction (PCR) testing rate is low in our local area and the true rate of coronavirus disease 2019 (COVID‐19) infection may include many asymptomatic individuals. We conducted a serosurveillance using antibody testing in an area where official report of COVID‐19 infection is not...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Akihiro, Ando, Sanae, Endo, Hideaki, Sato, Ryoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250612/
https://www.ncbi.nlm.nih.gov/pubmed/33760273
http://dx.doi.org/10.1002/jmv.26962
_version_ 1783717061057314816
author Nakamura, Akihiro
Ando, Sanae
Endo, Hideaki
Sato, Ryoichi
author_facet Nakamura, Akihiro
Ando, Sanae
Endo, Hideaki
Sato, Ryoichi
author_sort Nakamura, Akihiro
collection PubMed
description The polymerase chain reaction (PCR) testing rate is low in our local area and the true rate of coronavirus disease 2019 (COVID‐19) infection may include many asymptomatic individuals. We conducted a serosurveillance using antibody testing in an area where official report of COVID‐19 infection is not done yet. Blood samples were obtained from 1404 healthcare workers (41 ± 11 years) in our hospital on May 29–31, 2020. First, the potential infection frequency was confirmed using two quantitative antibody tests. In addition, the usefulness of rapid antibody kit testing for COVID‐19 serosurveillance was examined. A COVID‐19‐indected case was defined as showing positive results in both quantitative tests. None of 1404 samples had positive results from the two quantitative tests. The false positive rates were 0.36% and 0.07%, whereas those in rapid antibody kits were 3.3% and 3.0%. In conclusion, as of May, 2020, potential spread mainly by asymptomatic individuals infected with COVID‐19 was not found in our local area where there was no official report of COVID‐19, even if the PCR testing rate was low. Rapid antibody kits might not be useful due to the high false positive rate in an area with a low incidence of COVID‐19 infected individuals.
format Online
Article
Text
id pubmed-8250612
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82506122021-07-02 Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020 Nakamura, Akihiro Ando, Sanae Endo, Hideaki Sato, Ryoichi J Med Virol Short Communications The polymerase chain reaction (PCR) testing rate is low in our local area and the true rate of coronavirus disease 2019 (COVID‐19) infection may include many asymptomatic individuals. We conducted a serosurveillance using antibody testing in an area where official report of COVID‐19 infection is not done yet. Blood samples were obtained from 1404 healthcare workers (41 ± 11 years) in our hospital on May 29–31, 2020. First, the potential infection frequency was confirmed using two quantitative antibody tests. In addition, the usefulness of rapid antibody kit testing for COVID‐19 serosurveillance was examined. A COVID‐19‐indected case was defined as showing positive results in both quantitative tests. None of 1404 samples had positive results from the two quantitative tests. The false positive rates were 0.36% and 0.07%, whereas those in rapid antibody kits were 3.3% and 3.0%. In conclusion, as of May, 2020, potential spread mainly by asymptomatic individuals infected with COVID‐19 was not found in our local area where there was no official report of COVID‐19, even if the PCR testing rate was low. Rapid antibody kits might not be useful due to the high false positive rate in an area with a low incidence of COVID‐19 infected individuals. John Wiley and Sons Inc. 2021-04-03 2021-07 /pmc/articles/PMC8250612/ /pubmed/33760273 http://dx.doi.org/10.1002/jmv.26962 Text en © 2021 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communications
Nakamura, Akihiro
Ando, Sanae
Endo, Hideaki
Sato, Ryoichi
Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020
title Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020
title_full Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020
title_fullStr Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020
title_full_unstemmed Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020
title_short Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020
title_sort seroprevalence of antibodies to sars‐cov‐2 in healthcare workers in a nonepidemic region, japan: a hospital‐based study on may, 2020
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250612/
https://www.ncbi.nlm.nih.gov/pubmed/33760273
http://dx.doi.org/10.1002/jmv.26962
work_keys_str_mv AT nakamuraakihiro seroprevalenceofantibodiestosarscov2inhealthcareworkersinanonepidemicregionjapanahospitalbasedstudyonmay2020
AT andosanae seroprevalenceofantibodiestosarscov2inhealthcareworkersinanonepidemicregionjapanahospitalbasedstudyonmay2020
AT endohideaki seroprevalenceofantibodiestosarscov2inhealthcareworkersinanonepidemicregionjapanahospitalbasedstudyonmay2020
AT satoryoichi seroprevalenceofantibodiestosarscov2inhealthcareworkersinanonepidemicregionjapanahospitalbasedstudyonmay2020